Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ROCKWELL MEDICAL, INC.

Get SEC filing alerts via email and in your feed for ROCKWELL MEDICAL, INC.

RMTI

ROCKWELL MEDICAL, INC.

About ROCKWELL MEDICAL, INC.

Rockwell Medical develops and manufactures hemodialysis concentrates and related products for dialysis providers worldwide. Its core offerings include liquid and dry acid and bicarbonate concentrates, dialysates, and ancillary supplies used in end-stage kidney disease treatment. Serving clinics, hospitals, and international markets, the company emphasizes quality, reliability, and customer service, with a focus on growth through expanding customer base, product portfolio, and manufacturing efficiency within the renal care sector.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ROCKWELL MEDICAL, INC.

1
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports $17.3 Million in Net Sales, 8% Decrease in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports 31.8% Decline in Net Sales for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports 44% Decline in Q3 2025 Net Sales, Driven by Reduced Sales to DaVita

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports 38% Decline in Q2 2025 Net Sales, Net Loss of $3 Million

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports Q1 2025 Financial Results with $18.9M in Net Sales

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports 21.4% Revenue Growth to $101.5 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports 19% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments